Investigational New Drug application, prior to further use (4/25/13 Letter). This was after years of allowing it to be used for Clostridium difficile. Blood or bone samples are not considered drugs because they cannot be replicated, and neither can fecal material. There are 500,000 to 3,000,000 annual cases of C. difficile, and 14,000 related deaths. 5 After much objection, the FDA reversed its decision and no longer requires doctors to get approval before using fecal transplant, but only for C. difficile, and not IBD (6/17/13 Letter). It appears that someone already knows that fecal transfer is a promising treatment. A breakthrough, other than medical, is needed to help millions of suffering patients, some of whom will die.
